NTLA
Intellia Therapeutics, Inc
$12.08
0.00%
0.00
Notify me if price changes either direction
Buy NTLA stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.7B
Enterprise value
1.6B
Trailing PE
-3.1299213099042
Forward PE
-7.1501427
PEG Ratio
0.09034091053587
Enterprise to EBITDA
-3.926
Enterprise to revenue
24.428
Price to book MRQ
2.6517942
Price to sales TTM
28.899162
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-12-31
Revenue (TTM)
66.1M
EBITDA
-411244000
Diluted EPS TTM
-3.52
Total Cash (MRQ)
376.0M
Current ratio (MRQ)
6.102
Operating Cash Flow (TTM)
-363152000
NTLA trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
May 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
